Great news_老虎社区_美港股上老虎

VVTZ
2021-09-09

Great news

Moderna announces new combination vaccine candidate targeting COVID-19 and flu

(Sept 9) Moderna, Inc. jumped over 5% in early trading, after it announces new combination vaccine c

Moderna announces new combination vaccine candidate targeting COVID-19 and flu

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":883979769,"tweetId":"883979769","gmtCreate":1631198669851,"gmtModify":1631889152534,"author":{"id":3582629808245810,"idStr":"3582629808245810","authorId":3582629808245810,"authorIdStr":"3582629808245810","name":"VVTZ","avatar":"https://static.tigerbbs.com/2a29e08a133febe21814a6f15264733d","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":0,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Great news&nbsp;</p></body></html>","htmlText":"<html><head></head><body><p>Great news&nbsp;</p></body></html>","text":"Great news","highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/883979769","repostId":1169339361,"repostType":4,"repost":{"id":"1169339361","kind":"news","pubTimestamp":1631197303,"share":"https://www.laohu8.com/m/news/1169339361?lang=&edition=full","pubTime":"2021-09-09 22:21","market":"us","language":"en","title":"Moderna announces new combination vaccine candidate targeting COVID-19 and flu","url":"https://stock-news.laohu8.com/highlight/detail?id=1169339361","media":"seekingalpha","summary":"(Sept 9) Moderna, Inc. jumped over 5% in early trading, after it announces new combination vaccine c","content":"<p>(Sept 9)&nbsp;<a href=\"https://laohu8.com/S/MRNA\">Moderna, Inc.</a> jumped over 5% in early trading,&nbsp;after&nbsp;it announces new combination vaccine candidate targeting COVID-19 and flu.</p>\n<p><img src=\"https://static.tigerbbs.com/7eb113e06f2c08fc7e2b8910f8df71f8\" tg-width=\"1154\" tg-height=\"564\" referrerpolicy=\"no-referrer\"></p>\n<p>Moderna&nbsp;highlighted the strength of its pipeline and revised the cash position ahead of its R&amp;D Day Scheduled for&nbsp;Thursday at 8.00 AM EST.</p>\n<p>Issuing an update on R&amp;D programs, the company said it added a new combination vaccine candidate to the pipeline named mRNA-1073, which combines its COVID-19 vaccine and flu vaccine candidate.</p>\n<p>mRNA-1073, for which Moderna (MRNA) owns worldwide commercial rights, encodes for COVID-19 spike protein and the Flu HA glycoproteins.</p>\n<p>With 22 clinical studies currently underway, the company now boasts 37 programs in development across 34 development candidates.</p>\n<p>Updating the liquidity level, the company announced its cash position at about $15B as of August 31, up from ~$12.2B at the end&nbsp;of the previous quarter.</p>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna announces new combination vaccine candidate targeting COVID-19 and flu</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna announces new combination vaccine candidate targeting COVID-19 and flu\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-09 22:21 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3738257-moderna-updates-on-cash-position-and-unveils-new-combined-vaccine-candidate><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Sept 9) Moderna, Inc. jumped over 5% in early trading, after it announces new combination vaccine candidate targeting COVID-19 and flu.\n\nModerna highlighted the strength of its pipeline and revised ...</p>\n\n<a href=\"https://seekingalpha.com/news/3738257-moderna-updates-on-cash-position-and-unveils-new-combined-vaccine-candidate\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"https://seekingalpha.com/news/3738257-moderna-updates-on-cash-position-and-unveils-new-combined-vaccine-candidate","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1169339361","content_text":"(Sept 9) Moderna, Inc. jumped over 5% in early trading, after it announces new combination vaccine candidate targeting COVID-19 and flu.\n\nModerna highlighted the strength of its pipeline and revised the cash position ahead of its R&D Day Scheduled for Thursday at 8.00 AM EST.\nIssuing an update on R&D programs, the company said it added a new combination vaccine candidate to the pipeline named mRNA-1073, which combines its COVID-19 vaccine and flu vaccine candidate.\nmRNA-1073, for which Moderna (MRNA) owns worldwide commercial rights, encodes for COVID-19 spike protein and the Flu HA glycoproteins.\nWith 22 clinical studies currently underway, the company now boasts 37 programs in development across 34 development candidates.\nUpdating the liquidity level, the company announced its cash position at about $15B as of August 31, up from ~$12.2B at the end of the previous quarter.","news_type":1},"isVote":1,"tweetType":1,"viewCount":159,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":9,"xxTargetLangEnum":"ORIG"},"commentList":[],"hasMoreComment":false,"orderType":2}

Moderna announces new combination vaccine candidate targeting COVID-19 and flu

评论（1）

热议股票